Back to Search
Start Over
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein‐Barr virus capsid antigen: A mediation analysis
- Source :
- Cancer Medicine, Vol 9, Iss 5, Pp 1867-1876 (2020), Cancer Medicine
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Background The study aims are to evaluate the associations between nasopharyngeal carcinoma (NPC) risk and cigarette smoking and to explore the effects of cigarette smoking on Epstein‐Barr virus (EBV) infection for NPC risk. Methods 1235 male NPC cases and 1262 hospital‐based male controls matched to cases were recruited across six collaborative hospitals between 2010 and 2014. Using a standardized questionnaire, information on cigarette smoking and other potential risk factors for NPC was obtained. Blood was collected and used for anti‐EBV VCA IgA and anti‐EBV EA‐EBNA1 IgA testing using standard methods. Unconditional logistic regression analysis was used to estimate odds ratio (OR) with 95% confidence interval (CI) for each risk factor after adjusting for confounders. Results 63.6% of cases and 44.0% of controls reported ever smoking cigarettes. After full adjustment, current smokers had a significant 1.60‐fold (95% CI = 1.30‐1.97) and former smokers a borderline significant 1.27‐fold (95% CI = 1.00‐1.60) increased NPC risk compared to never smokers. NPC risk increased with increasing duration, intensity, and pack‐years of cigarette smoking but not with age at smoking initiation. Among controls, anti‐EBV VCA IgA seropositivity rate was higher in current smokers than never smokers (14.0% vs 8.4%; OR = 1.82; 95% CI = 1.19‐2.79). Mediation analyses showed that more than 90% of the cigarette smoking effect on NPC risk is mediated through anti‐EBV VCA IgA. Conclusion This study confirms the association between long‐term cigarette smoking and NPC and demonstrates that current smoking is associated with seropositivity of anti‐EBV VCA IgA antibodies.<br />Smoking duration and intensity but not age at initiation are NPC risk factors, and anti‐EBV VCA IgA seropositivity rate was higher in current than never smokers among controls. Mediation analyses show that NPC and EBV association may be explained by the interplay between smoking and EBV antibodies serostatus.
- Subjects :
- 0301 basic medicine
Male
Cancer Research
Epstein-Barr Virus Infections
Herpesvirus 4, Human
cigarette smoking
Logistic regression
Antibodies, Viral
0302 clinical medicine
Risk Factors
Antigens, Viral
Original Research
Smokers
Confounding
Middle Aged
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Epstein‐Barr Virus
Oncology
030220 oncology & carcinogenesis
Cancer Prevention
Adult
medicine.medical_specialty
Taiwan
Risk Assessment
lcsh:RC254-282
03 medical and health sciences
Internal medicine
medicine
otorhinolaryngologic diseases
Humans
Radiology, Nuclear Medicine and imaging
Risk factor
mediation analysis
Aged
business.industry
case‐control study
nasopharyngeal carcinoma
Case-control study
Nasopharyngeal Neoplasms
Odds ratio
Non-Smokers
Former Smoker
medicine.disease
Confidence interval
Immunoglobulin A
stomatognathic diseases
030104 developmental biology
Nasopharyngeal carcinoma
Case-Control Studies
Capsid Proteins
business
Ex-Smokers
Subjects
Details
- Language :
- English
- ISSN :
- 20457634
- Volume :
- 9
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Cancer Medicine
- Accession number :
- edsair.doi.dedup.....d3f0047bea8bb4b9722ad7452cc2f325